Literature DB >> 8426334

Combined small incision phacoemulsification and trabeculectomy.

B D Allan1, G D Barrett.   

Abstract

A method of combined cataract extraction and trabeculectomy is described in which phacoemulsification is performed through a 3.5 mm incision with insertion of a foldable hydrogel lens. This procedure is suitable for most cases in which glaucoma and cataract are coincident. In an initial series of ten patients followed for nine months, all those without additional pathology achieved a corrected visual acuity of 20/40 or better. The maximum induced astigmatism was 0.5 diopters (D), with no change or a reduction in astigmatism in seven patients (70%). Astigmatic shift between week 1 and three months was minimal (average = 0.075 D), with little change thereafter. Intraocular pressures were controlled (< or = 21 mm Hg) without adjunctive medication in all but one of the patients at nine months. This combined procedure preserves the principal advantages of small incision phacoemulsification: low induced astigmatism, early refractive stabilization, and rapid visual rehabilitation. In addition, reducing the extent of tissue dissection may reduce the stimulus to wound healing and early filtration failure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8426334     DOI: 10.1016/s0886-3350(13)80292-1

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  10 in total

1.  Comparison between phaco-deep sclerectomy and phaco-deep sclerectomy reconverted into phaco-trabeculectomy: series of fellow eyes.

Authors:  Carmen Cabarga-Nozal; Francisco Arnalich-Montiel; Roberto Fernández-Buenaga; Francisco J Hurtado-Ceña; Francisco J Muñoz-Negrete
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-01-15       Impact factor: 3.117

2.  Temporal corneal phacoemulsification combined with superior trabeculectomy: a controlled study.

Authors:  J Caprioli; H J Park; M Weitzman
Journal:  Trans Am Ophthalmol Soc       Date:  1996

3.  Changes in the morphology of the hyperemic blebs in eyes undergone trabeculectomy with mitomycin C after injection of triamcinolone acetonide during one-year follow-up.

Authors:  Zakieh Vahedian; Ghasem Fakhraie; Marzye Faraji; Seyed Mehdi Tabatabaei
Journal:  Int Ophthalmol       Date:  2021-06-25       Impact factor: 2.031

4.  Outcomes of 1.8-3.0 mm incision phacoemulsification combined with trabeculectomy for primary angle-closure glaucoma with cataract.

Authors:  Qing Wang; Zheng-Xuan Jiang; Rong-Feng Liao
Journal:  Int J Ophthalmol       Date:  2020-02-18       Impact factor: 1.779

5.  193 nm excimer laser sclerostomy in pseudophakic patients with advanced open angle glaucoma.

Authors:  B D Allan; P P van Saarloos; R L Cooper; I J Constable
Journal:  Br J Ophthalmol       Date:  1994-03       Impact factor: 4.638

6.  Combined phacoemulsification, intraocular lens implantation and trabeculectomy for chronic angle closure glaucoma.

Authors:  S L Tow; T Aung; F T Oen; S K Seah
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

7.  Visual and refractive outcome of one-site phacotrabeculectomy compared with temporal approach phacoemulsification.

Authors:  Daniela Vaideanu; Kaveri Mandal; Anthony Hildreth; Scott G Fraser; Peter S Phelan
Journal:  Clin Ophthalmol       Date:  2008-09

8.  Long-term visual field changes after femtosecond laser-assisted cataract surgery in glaucoma patients, case series.

Authors:  Daniela Alvarez-Ascencio; Carolina Prado-Larrea; Jesus Jimenez-Roman; Rafael Castañeda-Diez
Journal:  Am J Ophthalmol Case Rep       Date:  2021-07-09

9.  Surgically induced astigmatism following single site and twin site phacotrabeculectomy augmented with mitomycin C.

Authors:  Devendra Maheshwari; Ashwin Segi; Sarika Ramugade Shinde; Mohideen Abdul Kader; Ramakrishnan Rengappa
Journal:  Eye (Lond)       Date:  2021-06-11       Impact factor: 4.456

10.  One-site versus two-site phacotrabeculectomy: a prospective randomized study.

Authors:  Marilita M Moschos; Irini P Chatziralli; Michael Tsatsos
Journal:  Clin Interv Aging       Date:  2015-08-24       Impact factor: 4.458

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.